Gene · 9572
Papers2,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value of a circadian rhythm-related gene signature in breast cancer patients: A retrospective cohort study. | Medicine (Baltimore) | 2025 | 40826746 | PubTator, text mining | PubMed |
| Transcriptionally up-regulation of CDKN1A/p21 by TFE3 fusion proteins worsened TFE3-rearranged renal cell carcinoma. | Sci Rep | 2025 | 40820012 | PubTator, text mining | PubMed |
| Novel role of NR1D1 and SLC7A5 in gestational diabetes mellitus: regulation of polyamine metabolism. | J Diabetes Metab Disord | 2025 | 40735601 | PubTator, text mining | PubMed |
| Rev‑erbα: The circadian guardian against NLRP3‑driven liver fibrosis. | Mol Med Rep | 2025 | 40709400 | PubTator, text mining | PubMed |
| Morning clock gene expression in young adults of early and late chronotypes. | Sci Rep | 2025 | 40696102 | PubTator, text mining | PubMed |
| NR1D1 (REVERBalpha) may be novel candidate gene for coronary artery disease in men: Differential effects of NR1D1 polymorphisms by gender. | Chronobiol Int | 2025 | 40686381 | PubTator, text mining | PubMed |
Effect of Ramadan Fasting on Malondialdehyde, Poly (ADP-Ribose) Polymerase, Sirtuin 1, Nuclear Receptor Subfamily 1 Group D Member 1, and Transforming Growth Factor Beta in Chronic Kidney Disease: A Prospective Cohort Study. | Acta Med Indones | 2025 | 40641203 | PubTator, text mining | PubMed |
| Dysfunction of core clock genes regulates malignant phenotype and gemcitabine sensitivity of cholangiocarcinoma cells. | Anticancer Drugs | 2025 | 40526442 | PubTator, text mining | PubMed |
| Elucidation of the anti-arthritic mechanism of Guizhi-Shaoyao-Zhimu decoction by reshaping circadian rhythm. | Pharmacol Res | 2025 | 40412782 | PubTator, text mining | PubMed |
| NR1D1 mitigates IL-17a-induced small airway remodeling in biomass smoke-induced COPD. | Toxicol Lett | 2025 | 40345267 | PubTator, text mining | PubMed |
| Nutritional profile of the diet according to circadian clock genes in the European Prospective Investigation into Cancer and Nutrition (EPIC) chronodiet study. | Clin Nutr | 2025 | 40328174 | PubTator, text mining | PubMed |
The integration of scRNA-seq with microarray and in-vivo experiments facilitates a comprehensive elucidation of the molecular mechanisms underlying endothelial cell involvement in myocardial infarction. | Biochem Biophys Res Commun | 2025 | 40288264 | PubTator, text mining | PubMed |
| Exploring differences in signaling pathways of the circadian clock and neuromodulators in obstructive sleep apnea. | Sci Rep | 2025 | 40287460 | PubTator, text mining | PubMed |
| NR1D1::MAML3 Fusion in an Aggressive Mesenchymal Neoplasm. | Genes Chromosomes Cancer | 2025 | 40249078 | PubTator, text mining | PubMed |
| Core Molecular Clock Factors Regulate Osteosarcoma Stem Cell Survival and Behavior via CSC/EMT Pathways and Lipid Droplet Biogenesis. | Cells | 2025 | 40214471 | PubTator, text mining | PubMed |
| Light Exposure, Physical Activity, and Indigeneity Modulate Seasonal Variation in NR1D1 (REV-ERBα) Expression. | Biology (Basel) | 2025 | 40136488 | PubTator, text mining | PubMed |
| Correlation between levels of clock protein expression and effects on temozolomide-resistant glioblastoma and tumor progression. | Hum Cell | 2025 | 40123038 | PubTator, text mining | PubMed |
| Shuangxia Decoction attenuates sleep disruption in 5×FAD mice through neuroinflammation inhibition: An integrative analysis of transcriptomic and molecular biology investigations. | J Ethnopharmacol | 2025 | 40101857 | PubTator, text mining | PubMed |
| Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2. | ACS Pharmacol Transl Sci | 2025 | 40046426 | PubTator, text mining | PubMed |
| Transcription of Clock Genes in Medulloblastoma. | Cancers (Basel) | 2025 | 40002179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9572/papers?page=4